Global Cosmetic Surgery Market Report by Gender, Age Group, Procedure, End User, Countries and Company Analysis 2026-2034

Cosmetic Surgery Market Size and Forecast

Global cosmetic surgery market is projected to expand significantly, increasing from US$ 92.73 billion in 2025 to US$ 201.73 billion by 2034, representing a CAGR of 9.02% during 2026–2034. Market growth is being driven by increasing aesthetic awareness, greater acceptance of cosmetic enhancements, and the rising popularity of minimally invasive and advanced surgical procedures. Technological developments are improving treatment precision, safety, recovery times, and patient outcomes, encouraging more individuals to consider cosmetic procedures.

What is Cosmetic Surgery and Its Uses & Popularity Worldwide?

Cosmetic surgery refers to surgical procedures performed primarily to enhance, reshape, or improve the appearance of specific parts of the body. Unlike reconstructive surgery, which generally focuses on restoring function or appearance after injury, disease, or congenital conditions, cosmetic surgery is mainly performed for aesthetic purposes. Common procedures include breast augmentation, liposuction, rhinoplasty, facelift, eyelid surgery, tummy tuck, and body contouring.

Cosmetic surgery is used to modify body proportions, improve facial features, reduce excess fat or skin, and address visible signs of aging. Its popularity has increased worldwide as aesthetic awareness, disposable income, and acceptance of cosmetic enhancements continue to rise. Social media, changing beauty standards, celebrity influence, and greater access to information have also encouraged interest in aesthetic procedures. Technological advancements have made many procedures more precise and safer, while minimally invasive techniques can offer shorter recovery periods.

The growing availability of qualified practitioners, advanced surgical facilities, and personalized treatment options is further supporting adoption. As consumers increasingly prioritize appearance, confidence, and individualized aesthetic outcomes, cosmetic surgery continues to gain popularity across developed and emerging markets worldwide.

2024 Cosmetic Surgery Statistics at a Glance

Top 5 Surgical Procedures Worldwide

• Eyelid Surgery: 2,115,360 procedures, +13.4% compared with 2023.
• Liposuction: 2,087,189 procedures, −12.6%.
• Breast Augmentation: 1,658,615 procedures, −17.5%.
• Scar Revision: 1,156,446 procedures. This category was newly reported in the 2024 survey.
• Rhinoplasty: 1,083,631 procedures, −9.8%.

Top 5 Surgical Procedures for Women

• Liposuction: 1,792,323 procedures.
• Eyelid Surgery: 1,625,597 procedures.
• Breast Augmentation: 1,611,758 procedures.
• Abdominoplasty: 945,636 procedures.
• Scar Revision: 836,458 procedures.

Top 5 Surgical Procedures for Men

• Eyelid Surgery: 489,763 procedures.
• Gynecomastia: 383,656 procedures.
• Scar Revision: 319,987 procedures.
• Liposuction: 294,866 procedures.
• Rhinoplasty: 287,398 procedures.

Top 5 Non-Surgical Procedures Worldwide

• Botulinum Toxin: 7,887,955 procedures, −17.4% compared with 2023.
• Hyaluronic Acid: 6,338,184 procedures, +5.2%.
• Hair Removal: 1,487,130 procedures, −12.9%.
• Non-Surgical Skin Tightening: 1,239,306 procedures, +38.9%.
• Chemical Peel: 820,225 procedures, +33.3%.

Top 5 Non-Surgical Procedures for Women

• Botulinum Toxin: 6,622,473 procedures.
• Hyaluronic Acid: 5,458,666 procedures.
• Hair Removal: 1,224,695 procedures.
• Non-Surgical Skin Tightening: 1,046,361 procedures.
• Chemical Peel: 662,200 procedures.

Top 5 Non-Surgical Procedures for Men

• Botulinum Toxin: 1,265,482 procedures.
• Hyaluronic Acid: 879,517 procedures.
• Hair Removal: 262,435 procedures.
• Non-Surgical Skin Tightening: 192,946 procedures.
• Full-Field Ablative Treatment: 159,474 procedures.

Overall Global Aesthetic Procedure Statistics

• More than 17.4 million surgical procedures were performed by plastic surgeons worldwide in 2024.
• Approximately 20.5 million non-surgical procedures were performed during the year.
• Total surgical and non-surgical procedures increased by 42.5% between 2020 and 2024.
• The United States recorded more than 6.1 million total aesthetic procedures, ranking first globally.
• Brazil ranked second with approximately 3.1 million procedures, followed by Japan.

Age-Group Trends

• Approximately 54% of breast augmentations were performed among people aged 18–34 years.
• Around 60.1% of rhinoplasty procedures were performed among the 18–34 age group.
• Botulinum toxin was particularly popular among people aged 35–50 years, accounting for approximately 47% of procedures in this age group.

Source

• International Society of Aesthetic Plastic Surgery (ISAPS), Global Survey 2024 – International Survey on Aesthetic/Cosmetic Procedures Performed in 2024.

Growth Drivers of the Cosmetic Surgery Market

Rising Aesthetic Awareness and Changing Beauty Preferences

Increasing awareness of personal appearance is one of the major factors driving the global cosmetic surgery market. Social media platforms, digital advertising, celebrity culture, and beauty-focused content have made consumers more aware of aesthetic procedures and their potential outcomes. Cosmetic procedures are increasingly viewed as an option for improving appearance, confidence, and body proportions rather than being limited to traditional surgical applications. According to global industry estimates, more than 35 million aesthetic procedures are performed worldwide each year when surgical and non-surgical treatments are considered, demonstrating the broad acceptance of aesthetic medicine. Younger consumers are also becoming increasingly interested in treatments targeting facial features and body contouring. Common procedures such as liposuction, breast augmentation, rhinoplasty, eyelid surgery, and facelifts continue to attract substantial demand. Rising disposable incomes in developing economies are further improving access to elective procedures. In addition, greater availability of before-and-after information and online consultations is helping consumers make informed decisions. As aesthetic awareness continues to spread across different age groups and regions, demand for cosmetic surgery is expected to increase steadily.

Growing Popularity of Minimally Invasive and Advanced Procedures

Technological innovation and the increasing availability of minimally invasive aesthetic procedures are significantly supporting the cosmetic surgery market. Consumers increasingly prefer treatments that offer smaller incisions, reduced discomfort, shorter recovery periods, and improved aesthetic outcomes. Advanced technologies such as laser-assisted procedures, robotic surgical systems, energy-based devices, and computer-assisted planning are improving precision and patient safety. According to global aesthetic-procedure statistics, non-surgical treatments account for more than 80% of reported aesthetic procedures, highlighting the broader shift toward less invasive interventions. However, these technologies are also supporting the surgical segment by improving procedure planning, tissue handling, and postoperative recovery. Developments in liposuction, body contouring, breast surgery, facial rejuvenation, and reconstructive techniques are expanding treatment possibilities. The introduction of improved anesthesia methods and enhanced monitoring technologies is also helping reduce procedural risks. Furthermore, personalized treatment planning enables surgeons to tailor procedures according to individual anatomy and aesthetic goals. As technology continues to improve surgical precision and recovery outcomes, more consumers are expected to consider cosmetic procedures, supporting sustained market expansion.

Increasing Disposable Income and Accessibility of Cosmetic Procedures

Growing disposable income and improving access to qualified aesthetic professionals are creating significant opportunities for the cosmetic surgery market. As household incomes increase, particularly in emerging economies, consumers have greater ability to allocate spending toward elective healthcare and appearance-enhancing procedures. Countries across Asia-Pacific, Latin America, and the Middle East are experiencing increasing demand as private healthcare infrastructure and aesthetic clinics expand. Medical tourism is also contributing to market development because consumers frequently travel to countries offering specialized procedures at comparatively competitive prices. At the same time, the number of trained plastic surgeons and specialized aesthetic facilities is increasing in several regions, improving access to professional treatment. Global demographic trends are another important factor. The world’s population aged 60 years and older is projected to reach 2.1 billion by 2050, increasing demand for facial rejuvenation, eyelid surgery, facelifts, and body-contouring procedures associated with aging. Financing options, online consultations, and digital appointment systems are also making aesthetic services more accessible. As purchasing power, healthcare infrastructure, and professional availability improve, cosmetic surgery is expected to gain wider acceptance across developed and emerging markets.

Challenges of the Cosmetic Surgery Market

Surgical Risks, Complications, and Patient Safety Concerns

Potential surgical complications remain one of the most important challenges facing the cosmetic surgery market. Although advances in surgical techniques, anesthesia, medical monitoring, and postoperative care have improved safety, cosmetic procedures still involve risks such as infection, bleeding, scarring, anesthesia complications, asymmetry, implant-related problems, and the need for revision surgery. The level of risk varies substantially according to the procedure, patient characteristics, surgeon expertise, and healthcare setting. Rising demand can also create concerns regarding poorly qualified practitioners and unregulated facilities, particularly in markets where aesthetic procedures are rapidly expanding. Patients may be influenced by unrealistic expectations created through social media or digitally altered images, potentially resulting in dissatisfaction even when procedures are technically successful. Safety concerns can therefore discourage potential consumers from undergoing surgery. Regulatory authorities and professional organizations increasingly emphasize surgeon qualifications, accredited facilities, informed consent, patient screening, and appropriate postoperative monitoring. Maintaining strict safety standards is essential for sustaining consumer confidence. Manufacturers and healthcare providers must also ensure that implants, surgical devices, and other medical products meet established quality requirements to reduce complications and improve long-term patient outcomes.

High Treatment Costs and Regulatory Constraints

High procedure costs and regulatory requirements can limit the adoption of cosmetic surgery, particularly among price-sensitive consumers. Unlike medically necessary treatments, many cosmetic procedures are elective and are not routinely covered by health insurance, meaning patients generally pay the full cost themselves. Expenses can include surgeon fees, hospital or clinic charges, anesthesia, implants or specialized devices, medications, and follow-up appointments. Complex procedures may require additional revision surgeries, increasing the overall financial burden. Regulatory requirements also influence market development because cosmetic surgery involves medical devices, implants, pharmaceuticals, and specialized healthcare professionals. Obtaining approval for new technologies and ensuring compliance with safety standards can increase development costs and extend commercialization timelines. In addition, regulations regarding advertising, practitioner licensing, and clinical standards differ across countries, creating operational challenges for international providers. Economic uncertainty can further affect demand because consumers may postpone elective procedures when household budgets are under pressure. The growing availability of lower-cost providers and medical tourism can increase price competition, but it can also create concerns about quality and continuity of care. Balancing affordability, regulatory compliance, safety, and premium treatment quality will remain important for sustained market growth.

Cosmetic Surgery Launches / New Procedure Developments Worldwide

• Motiva Breast Implants – United States, 2024: Motiva breast implants received FDA approval in the U.S. in 2024 and became an important new option for breast augmentation. The implants feature advanced design characteristics intended to provide a more natural look and feel and potentially reduce certain implant-related complications.
• Letybo Botulinum Toxin – United States, 2024: Letybo received FDA approval in February 2024 for the temporary improvement of moderate-to-severe glabellar lines. Its introduction expanded the range of neuromodulator options available for aesthetic facial treatments.
• AirSculpt – United States, Expanded Cosmetic Applications, 2025–2026: AirSculpt has gained attention for minimally invasive fat-removal and body-contouring procedures. The technique is positioned as an alternative to traditional liposuction, with emphasis on smaller access points and reduced recovery requirements.
• Deep-Plane Midface Facelift – Global, 2025–2026: Advanced midface facelift techniques using smaller incisions and endoscopic approaches are gaining popularity, particularly among younger patients seeking more natural facial rejuvenation with potentially shorter recovery periods.
• Natural-Look Breast Augmentation – Global, 2025: Aesthetic practices are increasingly introducing and promoting lower-volume breast augmentation and implant-adjustment approaches. The trend emphasizes proportional results and subtle enhancement rather than dramatic changes.
• High-Definition Body Sculpting – United States, 2025: Advanced body-contouring procedures designed to create more defined abdominal, waist, and muscle contours are gaining attention. These approaches combine refined liposuction and fat-removal techniques to produce more athletic-looking outcomes.
• Post-Weight-Loss Body Contouring – Global, 2025: The increasing use of GLP-1 weight-loss medications has encouraged greater interest in cosmetic procedures for excess or loose skin, including tummy tucks, breast lifts, facelifts, neck lifts, and body contouring.
• Facial Fat Grafting – Global, 2024–2026: Fat grafting is gaining renewed attention as an alternative to some filler-based facial enhancement procedures. ISAPS reported approximately 0.9 million facial fat-grafting procedures in 2024, representing a 19.2% increase from the previous year.
• Submandibular Gland Contouring with Facelift – Global, 2026: Modern facelift approaches are increasingly incorporating submandibular gland contouring to improve jawline definition and create more integrated facial rejuvenation results.
• Alloclae Injectable Fat – United States, 2026: Alloclae, an injectable material derived from sterilized donor fat, has emerged as a novel aesthetic treatment being explored for volume restoration in areas such as the breasts, buttocks, and chest. The technology remains relatively new, and questions regarding long-term evidence and appropriate applications continue to be discussed.

Women Remain the Largest Consumer Group in Cosmetic Surgery

Female cosmetic surgery market represents the largest segment of global aesthetic procedures, supported by demand for body contouring, breast procedures, facial rejuvenation, and minimally invasive treatments. According to the International Society of Aesthetic Plastic Surgery (ISAPS), women accounted for approximately 85.5% of all aesthetic procedures performed by plastic surgeons globally in 2023. In 2024, liposuction remained the leading surgical cosmetic procedure among women, with approximately 1.79 million procedures, followed by eyelid surgery and breast augmentation. Female demand is also strong for non-surgical treatments, particularly botulinum toxin, hyaluronic acid, hair removal, and skin tightening. In 2023, women accounted for 84.8% of botulinum toxin procedures and 87.9% of hyaluronic acid procedures. Growing aesthetic awareness, social media influence, improved safety, personalized treatment options, and increasing acceptance of cosmetic enhancement are supporting this segment. The availability of minimally invasive alternatives is also encouraging women who may not prefer traditional surgery, creating sustained opportunities across both surgical and non-surgical categories.

Younger Consumers and Growing Interest in Facial and Body Enhancement

13–29 age cosmetic surgery market is increasingly influenced by social media, changing beauty preferences, celebrity culture, and greater awareness of aesthetic procedures. However, the younger age group should be considered carefully because cosmetic surgery among minors is subject to medical, ethical, and regulatory restrictions, while procedures for individuals aged 18–29 represent the more established commercial segment. Global ISAPS data show strong participation of 18–34-year-olds in several major cosmetic procedures. In 2024, approximately 54% of breast augmentations and 60.1% of rhinoplasty procedures were performed among people aged 18–34. In 2023, the corresponding shares were 53.7% for breast augmentation and 65.8% for rhinoplasty. Younger consumers commonly seek procedures related to facial appearance, body contouring, and breast enhancement. The increasing availability of consultations, digital imaging, minimally invasive treatments, and online information is improving awareness. At the same time, responsible patient screening, realistic expectations, psychological assessment when appropriate, and age-specific clinical guidelines remain essential for the responsible development of this market.

Increasing Demand for Body Contouring and Facial Surgery

Cosmetic surgical procedure market includes elective operations intended to improve or modify physical appearance, including liposuction, breast augmentation, eyelid surgery, rhinoplasty, abdominoplasty, and facelifts. Global demand remains substantial, with ISAPS reporting more than 17.4 million surgical aesthetic procedures performed by plastic surgeons worldwide in 2024. Surgical procedures increased by 42.5% between 2020 and 2024, demonstrating strong long-term recovery and expansion. In 2024, eyelid surgery became the most frequently performed surgical cosmetic procedure, followed by liposuction, breast augmentation, scar revision, and rhinoplasty. Eyelid surgery exceeded 2.1 million procedures, while liposuction remained particularly important among women. Improvements in anesthesia, surgical planning, postoperative monitoring, implant technology, and minimally invasive techniques are improving treatment precision and recovery. Growing demand for body contouring and facial rejuvenation is further supporting the segment. Increasing availability of qualified surgeons and specialized aesthetic facilities is also expanding access to procedures across developed and emerging economies.

Minimally Invasive Treatments Dominate Aesthetic Demand

Cosmetic non-surgical procedure market is expanding rapidly because consumers increasingly prefer treatments involving limited downtime, fewer surgical risks, and comparatively convenient recovery. According to ISAPS, approximately 20.5 million non-surgical aesthetic procedures were performed worldwide in 2024, compared with 17.4 million surgical procedures. Overall aesthetic procedures increased by 42.5% from 2020 to 2024, highlighting the strong expansion of non-surgical treatments. Botulinum toxin remained the leading non-surgical procedure, with approximately 7.8 million treatments in 2024, followed by hyaluronic-acid fillers, hair removal, non-surgical skin tightening, and chemical peels. Women account for the overwhelming majority of several non-surgical procedures; in 2023, women represented 84.8% of botulinum-toxin procedures and 87.9% of hyaluronic-acid procedures reported by ISAPS. Younger consumers are increasingly interested in preventive and appearance-enhancing treatments, while older consumers seek facial rejuvenation. Technological advances, shorter treatment times, and expanding product choices are expected to continue supporting market growth.

Specialized Facilities and Professional Treatment Supporting Expansion

Cosmetic surgery hospital and clinic market includes hospitals, dedicated plastic-surgery centers, aesthetic clinics, and physician offices providing surgical and non-surgical cosmetic procedures. Growing consumer demand is encouraging healthcare providers to expand aesthetic departments and invest in advanced surgical equipment, imaging technologies, treatment rooms, and specialized personnel. ISAPS reported that in 2023, cosmetic surgical procedures were performed primarily in hospitals, which accounted for 46.9% of procedures, followed by office facilities at 31.4%. This distribution demonstrates the important role of professionally equipped facilities in delivering aesthetic procedures. Clinics are increasingly adopting digital consultation platforms, 3D imaging, personalized treatment planning, and minimally invasive technologies to improve patient experience and operational efficiency. The growth of medical tourism is also creating opportunities for specialized cosmetic surgery centers in destinations offering experienced practitioners and competitive treatment costs. At the same time, patient safety, surgeon certification, facility accreditation, infection control, and regulatory compliance remain critical factors influencing consumer trust. As aesthetic procedures become more widely accepted, specialized hospitals and clinics are expected to remain central to the delivery of both surgical and non-surgical cosmetic treatments worldwide.

High Disposable Income and Advanced Aesthetic Infrastructure in the United States

United States cosmetic surgery market is one of the world’s largest and most established, supported by high consumer spending, sophisticated healthcare infrastructure, and widespread acceptance of aesthetic procedures. According to the American Society of Plastic Surgeons, U.S. plastic surgeons performed approximately 1.6 million cosmetic surgical procedures in 2023, demonstrating substantial consumer demand. Popular procedures include liposuction, breast augmentation, rhinoplasty, eyelid surgery, and facelifts, while minimally invasive treatments such as botulinum toxin and dermal fillers have expanded the overall aesthetic market. Social media, celebrity culture, and greater awareness of appearance are encouraging younger consumers to consider aesthetic treatments. Technological developments in 3D imaging, robotic assistance, energy-based devices, and AI-supported treatment planning are also improving precision and personalization. In addition, financing programs and the increasing availability of outpatient aesthetic clinics are making procedures more accessible. The United States also serves as an important center for medical research, device innovation, and professional training. Strong specialist availability, consumer awareness, and continuous development of surgical and minimally invasive techniques are expected to sustain the country’s cosmetic surgery market through the forecast period.

Germany Aging Population and Growing Demand for Aesthetic Treatments

Germany’s cosmetic surgery market is supported by a highly developed healthcare system, stringent quality standards, and increasing consumer interest in aesthetic and anti-aging procedures. The country’s aging population is an important demand driver, particularly for facelifts, eyelid surgery, body contouring, and other facial rejuvenation procedures. Germany has approximately 19 million people aged 65 years and older, creating a substantial demographic base for age-related aesthetic treatments. Minimally invasive procedures, including botulinum toxin injections and dermal fillers, are also gaining popularity because they generally involve shorter recovery periods than conventional surgery. Younger consumers are increasingly showing interest in preventive aesthetic treatments, influenced by social media, changing beauty preferences, and greater access to aesthetic information. Germany’s strong network of specialist clinics, qualified surgeons, and trained medical professionals supports professional consultation and treatment. Regulatory oversight further emphasizes patient safety, product quality, and appropriate clinical practices. In addition, Germany’s central location within Europe makes it accessible to international patients seeking specialized treatments. The combination of demographic aging, advanced healthcare infrastructure, professional expertise, and increasing aesthetic awareness is expected to support steady market development.

China Young Consumers and Rapid Expansion of Aesthetic Medicine

China has emerged as one of the world’s fastest-growing cosmetic surgery markets, supported by urbanization, rising disposable incomes, younger consumers, and strong beauty-oriented social trends. The country’s large population provides a substantial potential customer base, while growing purchasing power is increasing access to elective aesthetic procedures. Younger consumers are particularly important to the market, with demand spanning rhinoplasty, facial contouring, eyelid surgery, liposuction, dermal fillers, and skin-rejuvenation treatments. Social media platforms, online beauty communities, influencers, and digitally driven beauty trends have increased awareness of cosmetic procedures and encouraged consumers to explore aesthetic enhancements. China’s rapidly expanding digital economy is also changing how consumers discover clinics, compare treatments, and schedule consultations. The country has more than 1.4 billion people, creating significant long-term market potential even with relatively low penetration compared with mature markets. Investment in aesthetic medicine training, advanced equipment, and modern clinical facilities is improving treatment capabilities. However, concerns regarding unlicensed practitioners and unregulated facilities remain important challenges. Greater regulatory enforcement and consumer education are expected to improve market quality while supporting the continued expansion of China’s cosmetic surgery industry.

Saudi Arabia Healthcare Modernization and Increasing Acceptance of Aesthetic Procedures

Saudi Arabia’s cosmetic surgery market is expanding as aesthetic procedures become increasingly accepted among both women and men. Rising disposable incomes, changing lifestyle preferences, social media influence, and greater awareness of aesthetic treatments are contributing to demand for procedures such as liposuction, rhinoplasty, breast procedures, body contouring, and facial rejuvenation. Saudi Arabia has a particularly young population, with approximately 63% of Saudi citizens under the age of 30, creating a significant demographic base for appearance-related healthcare services. Healthcare modernization under Vision 2030 is supporting investment in advanced hospitals, specialized clinics, medical technologies, and professional healthcare capabilities. The country’s ambition to strengthen medical tourism is also creating opportunities for internationally trained specialists and high-quality aesthetic services. Increasing access to digital platforms enables consumers to research procedures, compare providers, and learn about treatment options before consultation. Premium aesthetic services are gaining attention among higher-income consumers, while specialized clinics are expanding their service portfolios. However, maintaining stringent practitioner licensing, facility standards, patient screening, and product safety remains essential. Continued healthcare investment, demographic growth, and increasing social acceptance are expected to support the Saudi Arabian cosmetic surgery market.

Recent Developments in Cosmetic Surgery Market

• June 2023: Aesthetic dermatology company Galderma secured FDA clearance for Restylane Eyelight, a dermal filler designed specifically for improving under-eye appearance. The approval strengthens the company’s portfolio and enhances its competitive position in the cosmetic injectables market.
• August 2023: U.S.-based medical technology firm TELA Bio, Inc. introduced its OviTex PRS Long-Term Resorbable device to the domestic market. The product is intended for use in reconstructive and plastic surgery procedures, expanding the company’s offerings in soft-tissue repair solutions.
• March 2023: Medical aesthetics manufacturer Establishment Labs Holdings Inc. revealed new partnership agreements with four European distributors and an additional partner network in Japan to support the launch of Mia Femtech, a minimally invasive 15-minute procedure designed to enhance breast shape.